{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:29:56Z","timestamp":1790983796172,"version":"4.1.0"},"reference-count":156,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T00:00:00Z","timestamp":1651017600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T00:00:00Z","timestamp":1651017600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Alzheimer\u2019s disease (AD) is the leading cause of dementia, clinically characterized by memory deficits and progressive cognitive decline. Despite decades of research effective therapies are lacking, and a large part of the genetic heritability remains unidentified.<jats:italic>ABCA7<\/jats:italic>and<jats:italic>ABCA1<\/jats:italic>, members of the ATP-binding cassette subfamily A (ABCA), were identified as AD risk genes in genome-wide association studies. Nevertheless, genetic and\/or functional studies propose a link between AD and two other members of the ABCA subclass, i.e., ABCA2 and ABCA5.<\/jats:p><\/jats:sec><jats:sec><jats:title>Main body<\/jats:title><jats:p>Changes in expression or dysfunction of these transporters were found to increase amyloid \u03b2 levels. This might be related to the common role of ABCA transporters in cellular cholesterol homeostasis, for which a prominent role in AD development has been suggested. In this review, we provide a comprehensive overview and discussion on the contribution of the ABCA subfamily to the etiopathogenesis of AD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>A better understanding of the function and identification of disease-associated genetic variants in ABCA transporters can contribute to the development of novel therapeutic strategies for AD.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13024-022-00536-w","type":"journal-article","created":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T11:03:15Z","timestamp":1651057395000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["The role of ATP-binding cassette subfamily A in the etiology of Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"17","author":[{"given":"Liene","family":"Bossaerts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Cacace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Van Broeckhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,27]]},"reference":[{"issue":"3","key":"536_CR1","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/alz.12328","volume":"17","author":"Alzheimer's disease facts and figures","year":"2021","unstructured":"Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 2021;17(3):327\u2013406.","journal-title":"Alzheimers Dement"},{"issue":"3","key":"536_CR2","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00401-012-0996-2","volume":"124","author":"GD Schellenberg","year":"2012","unstructured":"Schellenberg GD, Montine TJ. The genetics and neuropathology of Alzheimer\u2019s disease. Acta Neuropathol. 2012;124(3):305\u201323.","journal-title":"Acta Neuropathol"},{"issue":"6","key":"536_CR3","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.jalz.2016.01.012","volume":"12","author":"R Cacace","year":"2016","unstructured":"Cacace R, Sleegers K, Van Broeckhoven C. Molecular genetics of early-onset Alzheimer\u2019s disease revisited. Alzheimers Dement. 2016;12(6):733\u201348.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"536_CR4","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1001\/archneurol.2011.221","volume":"69","author":"TS Wingo","year":"2012","unstructured":"Wingo TS, et al. Autosomal Recessive Causes Likely in Early-Onset Alzheimer Disease. Arch Neurol. 2012;69(1):59\u201364.","journal-title":"Arch Neurol"},{"issue":"6311","key":"536_CR5","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/349704a0","volume":"349","author":"A Goate","year":"1991","unstructured":"Goate A, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer\u2019s disease. Nature. 1991;349(6311):704\u20136.","journal-title":"Nature"},{"issue":"6543","key":"536_CR6","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/376775a0","volume":"376","author":"EI Rogaev","year":"1995","unstructured":"Rogaev EI, et al. Familial Alzheimer\u2019s disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer\u2019s disease type 3 gene. Nature. 1995;376(6543):775\u20138.","journal-title":"Nature"},{"issue":"5226","key":"536_CR7","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1126\/science.7638622","volume":"269","author":"E Levy-Lahad","year":"1995","unstructured":"Levy-Lahad E, et al. Candidate gene for the chromosome 1 familial Alzheimer\u2019s disease locus. Science. 1995;269(5226):973\u20137.","journal-title":"Science"},{"issue":"1","key":"536_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1756-6606-4-3","volume":"4","author":"Y-W Zhang","year":"2011","unstructured":"Zhang Y-W, et al. APP processing in Alzheimer\u2019s disease. Mol Brain. 2011;4(1):3.","journal-title":"Mol Brain"},{"issue":"3","key":"536_CR9","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3390\/cells8030209","volume":"8","author":"N Oikawa","year":"2019","unstructured":"Oikawa N, Walter J. Presenilins and \u03b3-Secretase in Membrane Proteostasis. Cells. 2019;8(3):209.","journal-title":"Cells"},{"issue":"2","key":"536_CR10","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1001\/archpsyc.63.2.168","volume":"63","author":"M Gatz","year":"2006","unstructured":"Gatz M, et al. Role of Genes and Environments for Explaining Alzheimer Disease. Arch Gen Psychiatry. 2006;63(2):168\u201374.","journal-title":"Arch Gen Psychiatry"},{"issue":"6","key":"536_CR11","first-page":"1034","volume":"48","author":"MA Pericak-Vance","year":"1991","unstructured":"Pericak-Vance MA, et al. Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage. Am J Hum Genet. 1991;48(6):1034\u201350.","journal-title":"Am J Hum Genet"},{"issue":"5","key":"536_CR12","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","volume":"90","author":"WJ Strittmatter","year":"1993","unstructured":"Strittmatter WJ, et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA. 1993;90(5):1977\u201381.","journal-title":"Proc Natl Acad Sci USA"},{"key":"536_CR13","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3389\/fnins.2021.630502","volume":"15","author":"MA Husain","year":"2021","unstructured":"Husain MA, Laurent B, Plourde M. APOE and Alzheimer\u2019s Disease: From Lipid Transport to Physiopathology and Therapeutics. Front Neurosci. 2021;15:85.","journal-title":"Front Neurosci"},{"key":"536_CR14","unstructured":"Bellenguez, C., et al., New insights on the genetic etiology of Alzheimer\u2019s and related dementia. medRxiv, 2020: p. 2020.10.01.20200659."},{"issue":"5","key":"536_CR15","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/ng.803","volume":"43","author":"P Hollingworth","year":"2011","unstructured":"Hollingworth P, et al. Common variants at ABCA7, MS4A6A\/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer\u2019s disease. Nat Genet. 2011;43(5):429\u201335.","journal-title":"Nat Genet"},{"key":"536_CR16","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1146\/annurev.genom.6.080604.162122","volume":"6","author":"M Dean","year":"2005","unstructured":"Dean M, Annilo T. Evolution of the ATP-binding cassette (ABC) transporter superfamily in vertebrates. Annu Rev Genomics Hum Genet. 2005;6:123\u201342.","journal-title":"Annu Rev Genomics Hum Genet"},{"issue":"7","key":"536_CR17","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/S0022-2275(20)31588-1","volume":"42","author":"M Dean","year":"2001","unstructured":"Dean M, Hamon Y, Chimini G. The human ATP-binding cassette (ABC) transporter superfamily. J Lipid Res. 2001;42(7):1007\u201317.","journal-title":"J Lipid Res"},{"issue":"5","key":"536_CR18","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s00424-006-0126-x","volume":"453","author":"KJ Linton","year":"2007","unstructured":"Linton KJ, Higgins CF. Structure and function of ABC transporters: the ATP switch provides flexible control. Pfl\u00fcgers Arch Eur J Physiol. 2007;453(5):555\u201367.","journal-title":"Pfl\u00fcgers Arch Eur J Physiol"},{"issue":"2","key":"536_CR19","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S0022-2836(02)01105-1","volume":"325","author":"F Peelman","year":"2003","unstructured":"Peelman F, et al. Characterization of the ABCA Transporter Subfamily: Identification of Prokaryotic and Eukaryotic Members, Phylogeny and Topology. J Mol Biol. 2003;325(2):259\u201374.","journal-title":"J Mol Biol"},{"issue":"5","key":"536_CR20","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.bbadis.2006.01.011","volume":"1762","author":"WE Kaminski","year":"2006","unstructured":"Kaminski WE, Piehler A, Wenzel JJ. ABC A-subfamily transporters: Structure, function and disease. Biochimica et Biophysica Acta (BBA) - Mol Basis Dis. 2006;1762(5):510\u201324.","journal-title":"Biochimica et Biophysica Acta (BBA) - Mol Basis Dis"},{"issue":"5","key":"536_CR21","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1086\/429844","volume":"76","author":"DP Kelsell","year":"2005","unstructured":"Kelsell DP, et al. Mutations in ABCA12 underlie the severe congenital skin disease harlequin ichthyosis. Am J Hum Genet. 2005;76(5):794\u2013803.","journal-title":"Am J Hum Genet"},{"issue":"5","key":"536_CR22","doi-asserted-by":"publisher","first-page":"e1004333","DOI":"10.1371\/journal.pgen.1004333","volume":"10","author":"GM DeStefano","year":"2014","unstructured":"DeStefano GM, et al. Mutations in the cholesterol transporter gene ABCA5 are associated with excessive hair overgrowth. PLoS Genet. 2014;10(5):e1004333\u2013e1004333.","journal-title":"PLoS Genet"},{"issue":"13","key":"536_CR23","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1056\/NEJMoa032178","volume":"350","author":"S Shulenin","year":"2004","unstructured":"Shulenin S, et al. ABCA3 Gene Mutations in Newborns with Fatal Surfactant Deficiency. N Engl J Med. 2004;350(13):1296\u2013303.","journal-title":"N Engl J Med"},{"issue":"3","key":"536_CR24","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/ng0397-236","volume":"15","author":"R Allikmets","year":"1997","unstructured":"Allikmets R, et al. A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. Nat Genet. 1997;15(3):236\u201346.","journal-title":"Nat Genet"},{"issue":"4","key":"536_CR25","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/11914","volume":"22","author":"M Bodzioch","year":"1999","unstructured":"Bodzioch M, et al. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat Genet. 1999;22(4):347\u201351.","journal-title":"Nat Genet"},{"issue":"6","key":"536_CR26","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.ajhg.2009.11.003","volume":"85","author":"HM Knight","year":"2009","unstructured":"Knight HM, et al. A Cytogenetic Abnormality and Rare Coding Variants Identify ABCA13 as a Candidate Gene in Schizophrenia, Bipolar Disorder, and Depression. Am J Human Gen. 2009;85(6):833\u201346.","journal-title":"Am J Human Gen"},{"key":"536_CR27","doi-asserted-by":"publisher","first-page":"100166","DOI":"10.1074\/jbc.RA120.015997","volume":"296","author":"M Nakato","year":"2021","unstructured":"Nakato M, et al. ABCA13 dysfunction associated with psychiatric disorders causes impaired cholesterol trafficking. J Biol Chem. 2021;296:100166.","journal-title":"J Biol Chem"},{"issue":"5","key":"536_CR28","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/ng.801","volume":"43","author":"AC Naj","year":"2011","unstructured":"Naj AC, et al. Common variants at MS4A4\/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer\u2019s disease. Nat Genet. 2011;43(5):436\u201341.","journal-title":"Nat Genet"},{"issue":"9","key":"536_CR29","doi-asserted-by":"publisher","first-page":"5849","DOI":"10.1021\/acs.chemrev.8b00439","volume":"119","author":"X Cheng","year":"2019","unstructured":"Cheng X, Smith JC. Biological Membrane Organization and Cellular Signaling. Chem Rev. 2019;119(9):5849\u201380.","journal-title":"Chem Rev"},{"issue":"2","key":"536_CR30","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1097\/00041433-200104000-00003","volume":"12","author":"JM Dietschy","year":"2001","unstructured":"Dietschy JM, Turley SD. Cholesterol metabolism in the brain. Curr Opin Lipidol. 2001;12(2):105\u201312.","journal-title":"Curr Opin Lipidol"},{"issue":"4","key":"536_CR31","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.plipres.2011.06.002","volume":"50","author":"FW Pfrieger","year":"2011","unstructured":"Pfrieger FW, Ungerer N. Cholesterol metabolism in neurons and astrocytes. Prog Lipid Res. 2011;50(4):357\u201371.","journal-title":"Prog Lipid Res"},{"issue":"1","key":"536_CR32","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/bies.10195","volume":"25","author":"FW Pfrieger","year":"2003","unstructured":"Pfrieger FW. Outsourcing in the brain: do neurons depend on cholesterol delivery by astrocytes? BioEssays. 2003;25(1):72\u20138.","journal-title":"BioEssays"},{"issue":"39","key":"536_CR33","doi-asserted-by":"publisher","first-page":"40987","DOI":"10.1074\/jbc.M407963200","volume":"279","author":"SE Wahrle","year":"2004","unstructured":"Wahrle SE, et al. ABCA1 Is Required for Normal Central Nervous System ApoE Levels and for Lipidation of Astrocyte-secreted apoE*. J Biol Chem. 2004;279(39):40987\u201393.","journal-title":"J Biol Chem"},{"issue":"4","key":"536_CR34","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/1097-0029(20000815)50:4<297::AID-JEMT9>3.0.CO;2-C","volume":"50","author":"AM Fagan","year":"2000","unstructured":"Fagan AM, Holtzman DM. Astrocyte lipoproteins, effects of apoE on neuronal function, and role of apoE in amyloid-beta deposition in vivo. Microsc Res Tech. 2000;50(4):297\u2013304.","journal-title":"Microsc Res Tech"},{"issue":"18","key":"536_CR35","doi-asserted-by":"publisher","first-page":"9799","DOI":"10.1073\/pnas.93.18.9799","volume":"93","author":"D L\u00fctjohann","year":"1996","unstructured":"L\u00fctjohann D, et al. Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation. Proc Natl Acad Sci USA. 1996;93(18):9799\u2013804.","journal-title":"Proc Natl Acad Sci USA"},{"key":"536_CR36","doi-asserted-by":"crossref","unstructured":"Chang, T.-Y., et al., Acyl-coenzyme A:cholesterol acyltransferases. American journal of physiology. Endocrinology and metabolism, 2009. 297(1): p. E1-E9.","DOI":"10.1152\/ajpendo.90926.2008"},{"key":"536_CR37","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.brainres.2008.10.036","volume":"1249","author":"F Gosselet","year":"2009","unstructured":"Gosselet F, et al. Transcriptional profiles of receptors and transporters involved in brain cholesterol homeostasis at the blood\u2013brain barrier: Use of an in vitro model. Brain Res. 2009;1249:34\u201342.","journal-title":"Brain Res"},{"issue":"23","key":"536_CR38","doi-asserted-by":"publisher","first-page":"5490","DOI":"10.3390\/molecules25235490","volume":"25","author":"YY Cho","year":"2020","unstructured":"Cho YY, Kwon O-H, Chung S. Preferred Endocytosis of Amyloid Precursor Protein from Cholesterol-Enriched Lipid Raft Microdomains. Mol (Basel, Switzerland). 2020;25(23):5490.","journal-title":"Mol (Basel, Switzerland)"},{"issue":"10","key":"536_CR39","doi-asserted-by":"publisher","first-page":"5815","DOI":"10.1073\/pnas.081612998","volume":"98","author":"E Kojro","year":"2001","unstructured":"Kojro E, et al. Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the \u03b1-secretase ADAM 10. Proc Natl Acad Sci. 2001;98(10):5815\u201320.","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"536_CR40","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3233\/JAD-160826","volume":"56","author":"KJ Anstey","year":"2017","unstructured":"Anstey KJ, Ashby-Mitchell K, Peters R. Updating the Evidence on the Association between Serum Cholesterol and Risk of Late-Life Dementia: Review and Meta-Analysis. J Alzheimer\u2019s Dis\u202f: JAD. 2017;56(1):215\u201328.","journal-title":"J Alzheimer's Dis : JAD"},{"issue":"1","key":"536_CR41","doi-asserted-by":"crossref","first-page":"e12108","DOI":"10.1002\/trc2.12108","volume":"6","author":"G Torrandell-Haro","year":"2020","unstructured":"Torrandell-Haro G, et al. Statin therapy and risk of Alzheimer\u2019s and age-related neurodegenerative diseases. Alzheimers Dement (N Y). 2020;6(1):e12108.","journal-title":"Alzheimers Dement (N Y)"},{"issue":"6","key":"536_CR42","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/j.1365-2796.2006.01725.x","volume":"260","author":"I Bj\u00f6rkhem","year":"2006","unstructured":"Bj\u00f6rkhem I. Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain. J Intern Med. 2006;260(6):493\u2013508.","journal-title":"J Intern Med"},{"key":"536_CR43","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1146\/annurev.genom.1.1.507","volume":"1","author":"RW Mahley","year":"2000","unstructured":"Mahley RW, Rall SC Jr. Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet. 2000;1:507\u201337.","journal-title":"Annu Rev Genomics Hum Genet"},{"issue":"3","key":"536_CR44","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1136\/jnnp-2013-306485","volume":"85","author":"K Rannikm\u00e4e","year":"2014","unstructured":"Rannikm\u00e4e K, et al. APOE associations with severe CAA-associated vasculopathic changes: collaborative meta-analysis. J Neurol Neurosurg Psychiatry. 2014;85(3):300\u20135.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"89","key":"536_CR45","doi-asserted-by":"publisher","first-page":"89ra57","DOI":"10.1126\/scitranslmed.3002156","volume":"3","author":"JM Castellano","year":"2011","unstructured":"Castellano JM, et al. Human apoE isoforms differentially regulate brain amyloid-\u03b2 peptide clearance. Sci Trans Med. 2011;3(89):89ra57-89ra57.","journal-title":"Sci Trans Med"},{"issue":"5","key":"536_CR46","first-page":"1030","volume":"145","author":"T Wisniewski","year":"1994","unstructured":"Wisniewski T, et al. Acceleration of Alzheimer\u2019s fibril formation by apolipoprotein E in vitro. Am J Pathol. 1994;145(5):1030\u20135.","journal-title":"Am J Pathol"},{"issue":"38","key":"536_CR47","doi-asserted-by":"publisher","first-page":"23403","DOI":"10.1016\/S0021-9258(17)31529-6","volume":"269","author":"MJ LaDu","year":"1994","unstructured":"LaDu MJ, et al. Isoform-specific binding of apolipoprotein E to \u03b2-amyloid. J Biol Chem. 1994;269(38):23403\u20136.","journal-title":"J Biol Chem"},{"issue":"Pt 2","key":"536_CR48","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1042\/bj3480359","volume":"348 Pt 2","author":"T Tokuda","year":"2000","unstructured":"Tokuda T, et al. Lipidation of apolipoprotein E influences its isoform-specific interaction with Alzheimer\u2019s amyloid beta peptides. Biochem J. 2000;348 Pt 2(Pt 2):359\u201365.","journal-title":"Biochem J"},{"issue":"3","key":"536_CR49","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1046\/j.1471-4159.2000.0741008.x","volume":"74","author":"M Michikawa","year":"2000","unstructured":"Michikawa M, et al. Apolipoprotein E exhibits isoform-specific promotion of lipid efflux from astrocytes and neurons in culture. J Neurochem. 2000;74(3):1008\u201316.","journal-title":"J Neurochem"},{"issue":"3","key":"536_CR50","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41588-018-0311-9","volume":"51","author":"IE Jansen","year":"2019","unstructured":"Jansen IE, et al. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer\u2019s disease risk. Nat Genet. 2019;51(3):404\u201313.","journal-title":"Nat Genet"},{"issue":"3","key":"536_CR51","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","volume":"51","author":"BW Kunkle","year":"2019","unstructured":"Kunkle BW, et al. Genetic meta-analysis of diagnosed Alzheimer\u2019s disease identifies new risk loci and implicates A\u03b2, tau, immunity and lipid processing. Nat Genet. 2019;51(3):414\u201330.","journal-title":"Nat Genet"},{"issue":"10","key":"536_CR52","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1172\/JCI11538","volume":"106","author":"AR Tall","year":"2000","unstructured":"Tall AR, Wang N. Tangier disease as a test of the reverse cholesterol transport hypothesis. J Clin Investig. 2000;106(10):1205\u20137.","journal-title":"J Clin Investig"},{"issue":"12","key":"536_CR53","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1093\/qjmed\/hci136","volume":"98","author":"R Ohashi","year":"2005","unstructured":"Ohashi R, et al. Reverse cholesterol transport and cholesterol efflux in atherosclerosis. QJM: An Int J Med. 2005;98(12):845\u201356.","journal-title":"QJM: An Int J Med"},{"issue":"4","key":"536_CR54","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/11905","volume":"22","author":"A Brooks-Wilson","year":"1999","unstructured":"Brooks-Wilson A, et al. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet. 1999;22(4):336\u201345.","journal-title":"Nat Genet"},{"key":"536_CR55","doi-asserted-by":"crossref","unstructured":"Kim WS, et al. Quantitation of ATP-binding cassette subfamily-A transporter gene expression in primary human brain cells. Neuroreport.\u00a02006;17(9):891\u20136.","DOI":"10.1097\/01.wnr.0000221833.41340.cd"},{"issue":"1\u20132","key":"536_CR56","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s11010-011-0910-6","volume":"357","author":"TM Do","year":"2011","unstructured":"Do TM, et al. Direct evidence of abca1-mediated efflux of cholesterol at the mouse blood-brain barrier. Mol Cell Biochem. 2011;357(1\u20132):397\u2013404.","journal-title":"Mol Cell Biochem"},{"issue":"3","key":"536_CR57","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.3233\/JAD-161056","volume":"56","author":"NF Fitz","year":"2017","unstructured":"Fitz NF, et al. ABCA1 Deficiency Affects Basal Cognitive Deficits and Dendritic Density in Mice. J Alzheimer\u2019s Dis\u202f: JAD. 2017;56(3):1075\u201385.","journal-title":"J Alzheimer's Dis : JAD"},{"issue":"14","key":"536_CR58","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1093\/hmg\/ddx155","volume":"26","author":"J Zhao","year":"2017","unstructured":"Zhao J, et al. APOE \u03b54\/\u03b54 diminishes neurotrophic function of human iPSC-derived astrocytes. Hum Mol Genet. 2017;26(14):2690\u2013700.","journal-title":"Hum Mol Genet"},{"issue":"52","key":"536_CR59","doi-asserted-by":"publisher","first-page":"43224","DOI":"10.1074\/jbc.M504513200","volume":"280","author":"R Koldamova","year":"2005","unstructured":"Koldamova R, Staufenbiel M, Lefterov I. Lack of ABCA1 considerably decreases brain ApoE level and increases amyloid deposition in APP23 mice. J Biol Chem. 2005;280(52):43224\u201335.","journal-title":"J Biol Chem"},{"issue":"52","key":"536_CR60","doi-asserted-by":"publisher","first-page":"43236","DOI":"10.1074\/jbc.M508780200","volume":"280","author":"SE Wahrle","year":"2005","unstructured":"Wahrle SE, et al. Deletion of Abca1 Increases A\u03b2 Deposition in the PDAPP Transgenic Mouse Model of Alzheimer Disease*. J Biol Chem. 2005;280(52):43236\u201342.","journal-title":"J Biol Chem"},{"issue":"2","key":"536_CR61","doi-asserted-by":"publisher","first-page":"e00006","DOI":"10.1042\/AN20090015","volume":"1","author":"I Lefterov","year":"2009","unstructured":"Lefterov I, et al. Memory deficits in APP23\/Abca1+\/- mice correlate with the level of A\u03b2 oligomers. ASN neuro. 2009;1(2):e00006.","journal-title":"ASN neuro"},{"issue":"38","key":"536_CR62","doi-asserted-by":"publisher","first-page":"13125","DOI":"10.1523\/JNEUROSCI.1937-12.2012","volume":"32","author":"NF Fitz","year":"2012","unstructured":"Fitz NF, et al. Abca1 deficiency affects Alzheimer\u2019s disease-like phenotype in human ApoE4 but not in ApoE3-targeted replacement mice. J Neurosci. 2012;32(38):13125\u201336.","journal-title":"J Neurosci"},{"issue":"2","key":"536_CR63","first-page":"671","volume":"118","author":"SE Wahrle","year":"2008","unstructured":"Wahrle SE, et al. Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease. J Clin Invest. 2008;118(2):671\u201382.","journal-title":"J Clin Invest"},{"issue":"3","key":"536_CR64","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.3233\/JAD-160467","volume":"54","author":"A Boehm-Cagan","year":"2016","unstructured":"Boehm-Cagan A, et al. ABCA1 Agonist Reverses the ApoE4-Driven Cognitive and Brain Pathologies. J Alzheimers Dis. 2016;54(3):1219\u201333.","journal-title":"J Alzheimers Dis"},{"issue":"48","key":"536_CR65","doi-asserted-by":"publisher","first-page":"9611","DOI":"10.1523\/JNEUROSCI.1400-19.2019","volume":"39","author":"V Rawat","year":"2019","unstructured":"Rawat V, et al. ApoE4 Alters ABCA1 Membrane Trafficking in Astrocytes. J Neurosci. 2019;39(48):9611\u201322.","journal-title":"J Neurosci"},{"issue":"1","key":"536_CR66","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.stemcr.2021.11.007","volume":"17","author":"SM de Leeuw","year":"2022","unstructured":"de Leeuw SM, et al. APOE2, E3, and E4 differentially modulate cellular homeostasis, cholesterol metabolism, and inflammatory response in isogenic iPSC-derived astrocytes. Stem cell reports. 2022;17(1):110\u201326.","journal-title":"Stem cell reports"},{"issue":"36","key":"536_CR67","doi-asserted-by":"publisher","first-page":"28240","DOI":"10.1074\/jbc.M003337200","volume":"275","author":"P Costet","year":"2000","unstructured":"Costet P, et al. Sterol-dependent Transactivation of theABC1 Promoter by the Liver X Receptor\/Retinoid X Receptor*. J Biol Chem. 2000;275(36):28240\u20135.","journal-title":"J Biol Chem"},{"issue":"18","key":"536_CR68","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1111\/bph.14668","volume":"176","author":"NF Fitz","year":"2019","unstructured":"Fitz NF, et al. Therapeutic targeting of nuclear receptors, liver X and retinoid X receptors, for Alzheimer\u2019s disease. Br J Pharmacol. 2019;176(18):3599\u2013610.","journal-title":"Br J Pharmacol"},{"issue":"20","key":"536_CR69","doi-asserted-by":"publisher","first-page":"6862","DOI":"10.1523\/JNEUROSCI.1051-10.2010","volume":"30","author":"NF Fitz","year":"2010","unstructured":"Fitz NF, et al. Liver X receptor agonist treatment ameliorates amyloid pathology and memory deficits caused by high-fat diet in APP23 mice. J Neurosci. 2010;30(20):6862\u201372.","journal-title":"J Neurosci"},{"issue":"44","key":"536_CR70","doi-asserted-by":"publisher","first-page":"34144","DOI":"10.1074\/jbc.M110.108100","volume":"285","author":"JJ Donkin","year":"2010","unstructured":"Donkin JJ, et al. ATP-binding cassette transporter A1 mediates the beneficial effects of the liver X receptor agonist GW3965 on object recognition memory and amyloid burden in amyloid precursor protein\/presenilin 1 mice. J Biol Chem. 2010;285(44):34144\u201354.","journal-title":"J Biol Chem"},{"issue":"6","key":"536_CR71","doi-asserted-by":"publisher","first-page":"4079","DOI":"10.1074\/jbc.M411420200","volume":"280","author":"RP Koldamova","year":"2005","unstructured":"Koldamova RP, et al. The Liver X Receptor Ligand T0901317 Decreases Amyloid \u03b2 Production in Vitro and in a Mouse Model of Alzheimer\u2019s Disease*. J Biol Chem. 2005;280(6):4079\u201388.","journal-title":"J Biol Chem"},{"issue":"1","key":"536_CR72","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/S0925-4439(02)00066-2","volume":"1587","author":"S Ho Hong","year":"2002","unstructured":"Ho Hong S, et al. Novel ABCA1 compound variant associated with HDL cholesterol deficiency. Biochim Biophys Acta. 2002;1587(1):60\u20134.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"536_CR73","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1093\/hmg\/ddg007","volume":"12","author":"D Blacker","year":"2003","unstructured":"Blacker D, et al. Results of a high-resolution genome screen of 437 Alzheimer\u2019s Disease families. Hum Mol Genet. 2003;12(1):23\u201332.","journal-title":"Hum Mol Genet"},{"issue":"9\u201310","key":"536_CR74","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1016\/S0531-5565(00)00196-0","volume":"35","author":"MA Pericak-Vance","year":"2000","unstructured":"Pericak-Vance MA, et al. Identification of novel genes in late-onset Alzheimer\u2019s disease. Exp Gerontol. 2000;35(9\u201310):1343\u201352.","journal-title":"Exp Gerontol"},{"issue":"12","key":"536_CR75","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1016\/j.jalz.2015.04.006","volume":"11","author":"LT Nordestgaard","year":"2015","unstructured":"Nordestgaard LT, et al. Loss-of-function mutation in ABCA1 and risk of Alzheimer\u2019s disease and cerebrovascular disease. Alzheimers Dement. 2015;11(12):1430\u20138.","journal-title":"Alzheimers Dement"},{"issue":"6","key":"536_CR76","doi-asserted-by":"publisher","first-page":"e286","DOI":"10.1212\/NXG.0000000000000286","volume":"4","author":"GW Beecham","year":"2018","unstructured":"Beecham GW, et al. Rare genetic variation implicated in non-Hispanic white families with Alzheimer disease. Neurology Genetics. 2018;4(6):e286\u2013e286.","journal-title":"Neurology Genetics"},{"issue":"47","key":"536_CR77","doi-asserted-by":"publisher","first-page":"36091","DOI":"10.1074\/jbc.M602247200","volume":"281","author":"YD Landry","year":"2006","unstructured":"Landry YD, et al. ATP-binding Cassette Transporter A1 Expression Disrupts Raft Membrane Microdomains through Its ATPase-related Functions*. J Biol Chem. 2006;281(47):36091\u2013101.","journal-title":"J Biol Chem"},{"key":"536_CR78","doi-asserted-by":"crossref","unstructured":"Bossaerts, L., et al., Rare missense mutations in ABCA7 might increase Alzheimer\u2019s disease risk by plasma membrane exclusion. Acta Neuropathologica Communications, Preprint side Research Square, 2022.","DOI":"10.1186\/s40478-022-01346-3"},{"key":"536_CR79","doi-asserted-by":"publisher","first-page":"220.e1","DOI":"10.1016\/j.neurobiolaging.2017.07.001","volume":"59","author":"C Bellenguez","year":"2017","unstructured":"Bellenguez C, et al. Contribution to Alzheimer\u2019s disease risk of rare variants in TREM2, SORL1, and ABCA7 in 1779 cases and 1273 controls. Neurobiol Aging. 2017;59:220.e1-220.e9.","journal-title":"Neurobiol Aging"},{"issue":"3","key":"536_CR80","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s00401-017-1714-x","volume":"134","author":"A De Roeck","year":"2017","unstructured":"De Roeck A, et al. Deleterious ABCA7 mutations and transcript rescue mechanisms in early onset Alzheimer\u2019s disease. Acta Neuropathol. 2017;134(3):475\u201387.","journal-title":"Acta Neuropathol"},{"issue":"23","key":"536_CR81","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1212\/WNL.0000000000002627","volume":"86","author":"K Le Guennec","year":"2016","unstructured":"Le Guennec K, et al. ABCA7 rare variants and Alzheimer disease risk. Neurology. 2016;86(23):2134.","journal-title":"Neurology"},{"key":"536_CR82","doi-asserted-by":"publisher","first-page":"235.e1","DOI":"10.1016\/j.neurobiolaging.2016.04.004","volume":"46","author":"C Sassi","year":"2016","unstructured":"Sassi C, et al. ABCA7 p.G215S as potential protective factor for Alzheimer\u2019s disease. Neurobiol Aging. 2016;46:235.e1-235.e2359.","journal-title":"Neurobiol Aging"},{"key":"536_CR83","unstructured":"My Le, L.T., et al., Cryo-EM structure of lipid embedded human ABCA7 at 3.6\u00c5 resolution. bioRxiv, 2021: p. 2021.03.01.433448."},{"issue":"2","key":"536_CR84","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1006\/bbrc.2000.2954","volume":"273","author":"WE Kaminski","year":"2000","unstructured":"Kaminski WE, et al. Identification of a Novel Human Sterol-Sensitive ATP-Binding Cassette Transporter (ABCA7). Biochem Biophys Res Commun. 2000;273(2):532\u20138.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"536_CR85","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1006\/bbrc.2001.4305","volume":"281","author":"WE Kaminski","year":"2001","unstructured":"Kaminski WE, et al. Complete Coding Sequence, Promoter Region, and Genomic Structure of the Human ABCA2 Gene and Evidence for Sterol-Dependent Regulation in Macrophages. Biochem Biophys Res Commun. 2001;281(1):249\u201358.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"536_CR86","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1006\/geno.1994.1237","volume":"21","author":"MF Luciani","year":"1994","unstructured":"Luciani MF, et al. Cloning of Two Novel ABC Transporters Mapping on Human Chromosome 9. Genomics. 1994;21(1):150\u20139.","journal-title":"Genomics"},{"issue":"8","key":"536_CR87","first-page":"3339","volume":"61","author":"B Vulevic","year":"2001","unstructured":"Vulevic B, et al. Cloning and Characterization of Human Adenosine 5\u2032-triphosphate-binding Cassette, Sub-family A, Transporter 2 (<em>ABCA2<\/em>). Can Res. 2001;61(8):3339.","journal-title":"Can Res"},{"issue":"2","key":"536_CR88","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/j.1471-4159.2006.03714.x","volume":"97","author":"C Broccardo","year":"2006","unstructured":"Broccardo C, et al. ABCA2 is a marker of neural progenitors and neuronal subsets in the adult rodent brain. J Neurochem. 2006;97(2):345\u201355.","journal-title":"J Neurochem"},{"issue":"1\u20133","key":"536_CR89","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.bbalip.2004.04.009","volume":"1683","author":"W Davis Jr","year":"2004","unstructured":"Davis W Jr, et al. Human ATP-binding cassette transporter-2 (ABCA2) positively regulates low-density lipoprotein receptor expression and negatively regulates cholesterol esterification in Chinese hamster ovary cells. Biochim Biophys Acta. 2004;1683(1\u20133):89\u2013100.","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"536_CR90","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1074\/jbc.M607831200","volume":"282","author":"WS Kim","year":"2007","unstructured":"Kim WS, et al. Role of ABCG1 and ABCA1 in Regulation of Neuronal Cholesterol Efflux to Apolipoprotein E Discs and Suppression of Amyloid-\u03b2 Peptide Generation*. J Biol Chem. 2007;282(5):2851\u201361.","journal-title":"J Biol Chem"},{"issue":"12","key":"536_CR91","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/j.bbalip.2011.07.010","volume":"1811","author":"W Davis Jr","year":"2011","unstructured":"Davis W Jr. The ATP-binding cassette transporter-2 (ABCA2) regulates cholesterol homeostasis and low-density lipoprotein receptor metabolism in N2a neuroblastoma cells. Biochim Biophys Acta. 2011;1811(12):1152\u201364.","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"536_CR92","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/cne.10493","volume":"455","author":"Y Tanaka","year":"2003","unstructured":"Tanaka Y, et al. Temporal and spatial profiles of ABCA2-expressing oligodendrocytes in the developing rat brain. J Comp Neurol. 2003;455(3):353\u201367.","journal-title":"J Comp Neurol"},{"issue":"4","key":"536_CR93","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1002\/cne.10354","volume":"451","author":"CJ Zhou","year":"2002","unstructured":"Zhou CJ, et al. ATP-binding cassette transporter ABCA2 (ABC2) expression in the developing spinal cord and PNS during myelination. J Comp Neurol. 2002;451(4):334\u201345.","journal-title":"J Comp Neurol"},{"issue":"1","key":"536_CR94","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1128\/MCB.01824-06","volume":"27","author":"JT Mack","year":"2007","unstructured":"Mack JT, et al. \u201cSkittish\u201d Abca2 knockout mice display tremor, hyperactivity, and abnormal myelin ultrastructure in the central nervous system. Mol Cell Biol. 2007;27(1):44\u201353.","journal-title":"Mol Cell Biol"},{"issue":"27","key":"536_CR95","doi-asserted-by":"publisher","first-page":"19692","DOI":"10.1074\/jbc.M611056200","volume":"282","author":"H Sakai","year":"2007","unstructured":"Sakai H, et al. ABCA2 Deficiency Results in Abnormal Sphingolipid Metabolism in Mouse Brain*. J Biol Chem. 2007;282(27):19692\u20139.","journal-title":"J Biol Chem"},{"issue":"10","key":"536_CR96","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1096\/fj.03-1490fje","volume":"18","author":"ZJ Chen","year":"2004","unstructured":"Chen ZJ, et al. Association of ABCA2 expression with determinants of Alzheimer\u2019s disease. Faseb j. 2004;18(10):1129\u201331.","journal-title":"Faseb j"},{"issue":"7","key":"536_CR97","doi-asserted-by":"publisher","first-page":"566","DOI":"10.2174\/156720510793499002","volume":"7","author":"W Davis Jr","year":"2010","unstructured":"Davis W Jr. The ATP-binding cassette transporter-2 (ABCA2) increases endogenous amyloid precursor protein expression and A\u03b2 fragment generation. Curr Alzheimer Res. 2010;7(7):566\u201377.","journal-title":"Curr Alzheimer Res"},{"issue":"2","key":"536_CR98","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1074\/jbc.M111.288258","volume":"287","author":"V Michaki","year":"2012","unstructured":"Michaki V, et al. Down-regulation of the ATP-binding cassette transporter 2 (Abca2) reduces amyloid-\u03b2 production by altering Nicastrin maturation and intracellular localization. J Biol Chem. 2012;287(2):1100\u201311.","journal-title":"J Biol Chem"},{"issue":"33","key":"536_CR99","doi-asserted-by":"publisher","first-page":"31261","DOI":"10.1074\/jbc.M304122200","volume":"278","author":"OM Grbovic","year":"2003","unstructured":"Grbovic OM, et al. Rab5-stimulated up-regulation of the endocytic pathway increases intracellular beta-cleaved amyloid precursor protein carboxyl-terminal fragment levels and Abeta production. J Biol Chem. 2003;278(33):31261\u20138.","journal-title":"J Biol Chem"},{"key":"536_CR100","doi-asserted-by":"publisher","first-page":"5851","DOI":"10.12659\/MSM.905524","volume":"23","author":"W Hu","year":"2017","unstructured":"Hu W, et al. ATP Binding Cassette Subfamily A Member 2 (ABCA2) Expression and Methylation are Associated with Alzheimer\u2019s Disease. Medical Science Monit. 2017;23:5851\u201361.","journal-title":"Medical Science Monit"},{"issue":"1","key":"536_CR101","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.nbd.2004.09.011","volume":"18","author":"S Mac\u00e9","year":"2005","unstructured":"Mac\u00e9 S, et al. ABCA2 is a strong genetic risk factor for early-onset Alzheimer\u2019s disease. Neurobiol Dis. 2005;18(1):119\u201325.","journal-title":"Neurobiol Dis"},{"issue":"5","key":"536_CR102","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1002\/ajmg.b.30345","volume":"141b","author":"MA Wollmer","year":"2006","unstructured":"Wollmer MA, et al. Ethnicity-dependent genetic association of ABCA2 with sporadic Alzheimer\u2019s disease. Am J Med Genet B Neuropsychiatr Genet. 2006;141b(5):534\u20136.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"11","key":"536_CR103","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1016\/j.neurobiolaging.2008.01.006","volume":"30","author":"RL Minster","year":"2009","unstructured":"Minster RL, DeKosky ST, Kamboh MI. No association of DAPK1 and ABCA2 SNPs on chromosome 9 with Alzheimer\u2019s disease. Neurobiol Aging. 2009;30(11):1890\u20131.","journal-title":"Neurobiol Aging"},{"issue":"9","key":"536_CR104","doi-asserted-by":"publisher","first-page":"e73129","DOI":"10.1371\/journal.pone.0073129","volume":"8","author":"X Xu","year":"2013","unstructured":"Xu X, et al. Meta-analyses of 8 polymorphisms associated with the risk of the Alzheimer\u2019s disease. PLoS ONE. 2013;8(9):e73129\u2013e73129.","journal-title":"PLoS ONE"},{"issue":"3","key":"536_CR105","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1046\/j.1466-920x.2001.00038.x","volume":"1","author":"I Arnould","year":"2001","unstructured":"Arnould I, et al. Identifying and characterizing a five-gene cluster of ATP-binding cassette transporters mapping to human chromosome 17q24: a new subgroup within the ABCA subfamily. Genescreen. 2001;1(3):157\u201364.","journal-title":"Genescreen"},{"issue":"3","key":"536_CR106","doi-asserted-by":"publisher","first-page":"857","DOI":"10.3233\/JAD-141320","volume":"43","author":"Y Fu","year":"2015","unstructured":"Fu Y, et al. ABCA5 regulates amyloid-\u03b2 peptide production and is associated with Alzheimer\u2019s disease neuropathology. J Alzheimers Dis. 2015;43(3):857\u201369.","journal-title":"J Alzheimers Dis"},{"issue":"17","key":"536_CR107","doi-asserted-by":"publisher","first-page":"4922","DOI":"10.1016\/j.jmb.2020.07.006","volume":"432","author":"AG Ray","year":"2020","unstructured":"Ray AG, et al. Novel Mechanism of Cholesterol Transport by ABCA5 in Macrophages and Its Role in Dyslipidemia. J Mol Biol. 2020;432(17):4922\u201341.","journal-title":"J Mol Biol"},{"issue":"1","key":"536_CR108","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3233\/JPD-2012-11059","volume":"2","author":"WS Kim","year":"2012","unstructured":"Kim WS, Halliday GM. Changes in sphingomyelin level affect alpha-synuclein and ABCA5 expression. J Parkinsons Dis. 2012;2(1):41\u20136.","journal-title":"J Parkinsons Dis"},{"issue":"10","key":"536_CR109","doi-asserted-by":"publisher","first-page":"4138","DOI":"10.1128\/MCB.25.10.4138-4149.2005","volume":"25","author":"Y Kubo","year":"2005","unstructured":"Kubo Y, et al. ABCA5 resides in lysosomes, and ABCA5 knockout mice develop lysosomal disease-like symptoms. Mol Cell Biol. 2005;25(10):4138\u201349.","journal-title":"Mol Cell Biol"},{"issue":"12","key":"536_CR110","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1038\/ng.487","volume":"41","author":"J Sim\u00f3n-S\u00e1nchez","year":"2009","unstructured":"Sim\u00f3n-S\u00e1nchez J, et al. Genome-wide association study reveals genetic risk underlying Parkinson\u2019s disease. Nat Genet. 2009;41(12):1308\u201312.","journal-title":"Nat Genet"},{"issue":"1","key":"536_CR111","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3233\/JAD-2010-100324","volume":"21","author":"WS Kim","year":"2010","unstructured":"Kim WS, et al. Increased ATP-binding cassette transporter A1 expression in Alzheimer\u2019s disease hippocampal neurons. J Alzheimers Dis. 2010;21(1):193\u2013205.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"536_CR112","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1074\/jbc.M309888200","volume":"279","author":"S Abe-Dohmae","year":"2004","unstructured":"Abe-Dohmae S, et al. Human ABCA7 Supports Apolipoprotein-mediated Release of Cellular Cholesterol and Phospholipid to Generate High Density Lipoprotein*. J Biol Chem. 2004;279(1):604\u201311.","journal-title":"J Biol Chem"},{"issue":"2","key":"536_CR113","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.bbrc.2003.10.002","volume":"311","author":"Y Ikeda","year":"2003","unstructured":"Ikeda Y, et al. Posttranscriptional regulation of human ABCA7 and its function for the apoA-I-dependent lipid release. Biochem Biophys Res Commun. 2003;311(2):313\u20138.","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"536_CR114","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1194\/jlr.M500092-JLR200","volume":"46","author":"M Hayashi","year":"2005","unstructured":"Hayashi M, et al. Heterogeneity of high density lipoprotein generated by ABCA1 and ABCA7. J Lipid Res. 2005;46(8):1703\u201311.","journal-title":"J Lipid Res"},{"issue":"1","key":"536_CR115","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1194\/jlr.M400247-JLR200","volume":"46","author":"P Linsel-Nitschke","year":"2005","unstructured":"Linsel-Nitschke P, et al. Potential role of ABCA7 in cellular lipid efflux to apoA-I. J Lipid Res. 2005;46(1):86\u201392.","journal-title":"J Lipid Res"},{"issue":"5","key":"536_CR116","doi-asserted-by":"publisher","first-page":"3989","DOI":"10.1074\/jbc.M412602200","volume":"280","author":"WS Kim","year":"2005","unstructured":"Kim WS, et al. Abca7 Null Mice Retain Normal Macrophage Phosphatidylcholine and Cholesterol Efflux Activity despite Alterations in Adipose Mass and Serum Cholesterol Levels*. J Biol Chem. 2005;280(5):3989\u201395.","journal-title":"J Biol Chem"},{"issue":"9","key":"536_CR117","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1194\/jlr.M006049","volume":"51","author":"N Tanaka","year":"2010","unstructured":"Tanaka N, et al. Helical apolipoproteins of high-density lipoprotein enhance phagocytosis by stabilizing ATP-binding cassette transporter A7. J Lipid Res. 2010;51(9):2591\u20139.","journal-title":"J Lipid Res"},{"issue":"9","key":"536_CR118","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1194\/jlr.M600127-JLR200","volume":"47","author":"N Iwamoto","year":"2006","unstructured":"Iwamoto N, et al. ABCA7 expression is regulated by cellular cholesterol through the SREBP2 pathway and associated with phagocytosis. J Lipid Res. 2006;47(9):1915\u201327.","journal-title":"J Lipid Res"},{"issue":"4","key":"536_CR119","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/j.febslet.2005.12.029","volume":"580","author":"S Abe-Dohmae","year":"2006","unstructured":"Abe-Dohmae S, Ueda K, Yokoyama S. ABCA7, a molecule with unknown function. FEBS Lett. 2006;580(4):1178\u201382.","journal-title":"FEBS Lett"},{"issue":"1","key":"536_CR120","doi-asserted-by":"publisher","first-page":"40273","DOI":"10.1038\/srep40273","volume":"7","author":"HN Nowyhed","year":"2017","unstructured":"Nowyhed HN, et al. ATP Binding Cassette Transporter ABCA7 Regulates NKT Cell Development and Function by Controlling CD1d Expression and Lipid Raft Content. Sci Rep. 2017;7(1):40273.","journal-title":"Sci Rep"},{"issue":"6","key":"536_CR121","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S0092-8674(00)81201-5","volume":"93","author":"Y-C Wu","year":"1998","unstructured":"Wu Y-C, Horvitz H.R. The C. elegans Cell Corpse Engulfment Gene ced-7 Encodes a Protein Similar to ABC Transporters. Cell. 1998;93(6):951\u201360.","journal-title":"Cell"},{"issue":"4","key":"536_CR122","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1083\/jcb.200601030","volume":"174","author":"AW Jehle","year":"2006","unstructured":"Jehle AW, et al. ATP-binding cassette transporter A7 enhances phagocytosis of apoptotic cells and associated ERK signaling in macrophages. J Cell Biol. 2006;174(4):547\u201356.","journal-title":"J Cell Biol"},{"issue":"2","key":"536_CR123","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.atherosclerosis.2011.06.031","volume":"217","author":"N Tanaka","year":"2011","unstructured":"Tanaka N, et al. HMG-CoA reductase inhibitors enhance phagocytosis by upregulating ATP-binding cassette transporter A7. Atherosclerosis. 2011;217(2):407\u201314.","journal-title":"Atherosclerosis"},{"issue":"7","key":"536_CR124","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1194\/jlr.R075796","volume":"58","author":"M Shinohara","year":"2017","unstructured":"Shinohara M, et al. Role of LRP1 in the pathogenesis of Alzheimer\u2019s disease: evidence from clinical and preclinical studies: Thematic Review Series: ApoE and Lipid Homeostasis in Alzheimer\u2019s Disease. J Lipid Res. 2017;58(7):1267\u201381.","journal-title":"J Lipid Res"},{"issue":"47","key":"536_CR125","doi-asserted-by":"publisher","first-page":"23790","DOI":"10.1073\/pnas.1908529116","volume":"116","author":"T Aikawa","year":"2019","unstructured":"Aikawa T, et al. ABCA7 haplodeficiency disturbs microglial immune responses in the mouse brain. Proc Natl Acad Sci USA. 2019;116(47):23790\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"536_CR126","doi-asserted-by":"publisher","first-page":"e45959","DOI":"10.1371\/journal.pone.0045959","volume":"7","author":"W Logge","year":"2012","unstructured":"Logge W, et al. Role of Abca7 in mouse behaviours relevant to neurodegenerative diseases. PLoS ONE. 2012;7(9):e45959\u2013e45959.","journal-title":"PLoS ONE"},{"issue":"40","key":"536_CR127","doi-asserted-by":"publisher","first-page":"24152","DOI":"10.1074\/jbc.M115.655076","volume":"290","author":"K Satoh","year":"2015","unstructured":"Satoh K, et al. ATP-binding cassette transporter A7 (ABCA7) loss of function alters Alzheimer amyloid processing. J Biol Chem. 2015;290(40):24152\u201365.","journal-title":"J Biol Chem"},{"issue":"13","key":"536_CR128","doi-asserted-by":"publisher","first-page":"3848","DOI":"10.1523\/JNEUROSCI.3757-15.2016","volume":"36","author":"N Sakae","year":"2016","unstructured":"Sakae N, et al. ABCA7 Deficiency Accelerates Amyloid-\u03b2 Generation and Alzheimer\u2019s Neuronal Pathology. J Neurosci. 2016;36(13):3848\u201359.","journal-title":"J Neurosci"},{"issue":"4","key":"536_CR129","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s12031-017-0889-x","volume":"61","author":"M Li","year":"2017","unstructured":"Li M, et al. Study on Lentivirus-Mediated ABCA7 Improves Neurocognitive Function and Related Mechanisms in the C57BL\/6 Mouse Model of Alzheimer\u2019s Disease. J Mol Neurosci. 2017;61(4):489\u201397.","journal-title":"J Mol Neurosci"},{"issue":"10","key":"536_CR130","doi-asserted-by":"publisher","first-page":"4387","DOI":"10.1523\/JNEUROSCI.4165-12.2013","volume":"33","author":"WS Kim","year":"2013","unstructured":"Kim WS, et al. Deletion of Abca7 increases cerebral amyloid-\u03b2 accumulation in the J20 mouse model of Alzheimer\u2019s disease. J Neurosci. 2013;33(10):4387\u201394.","journal-title":"J Neurosci"},{"key":"536_CR131","doi-asserted-by":"publisher","first-page":"569","DOI":"10.3233\/JAD-160456","volume":"54","author":"Y Fu","year":"2016","unstructured":"Fu Y, et al. ABCA7 Mediates Phagocytic Clearance of Amyloid-\u03b2 in the Brain. J Alzheimers Dis. 2016;54:569\u201384.","journal-title":"J Alzheimers Dis"},{"key":"536_CR132","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.3233\/JAD-170883","volume":"64","author":"Y Lamartini\u00e8re","year":"2018","unstructured":"Lamartini\u00e8re Y, et al. ABCA7 Downregulation Modifies Cellular Cholesterol Homeostasis and Decreases Amyloid-\u03b2 Peptide Efflux in an in vitro Model of the Blood-Brain Barrier. J Alzheimers Dis. 2018;64:1195\u2013211.","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"536_CR133","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/alz.12220","volume":"17","author":"NN Lyssenko","year":"2021","unstructured":"Lyssenko NN, Pratic\u00f2 D. ABCA7 and the altered lipidostasis hypothesis of Alzheimer\u2019s disease. Alzheimer\u2019s Dementia. 2021;17(2):164\u201374.","journal-title":"Alzheimer's Dementia"},{"issue":"12","key":"536_CR134","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/ng.2802","volume":"45","author":"J-C Lambert","year":"2013","unstructured":"Lambert J-C, et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease. Nat Genet. 2013;45(12):1452\u20138.","journal-title":"Nat Genet"},{"issue":"12","key":"536_CR135","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1001\/archneurol.2011.646","volume":"68","author":"MW Logue","year":"2011","unstructured":"Logue MW, et al. A Comprehensive Genetic Association Study of Alzheimer Disease in African Americans. Arch Neurol. 2011;68(12):1569\u201379.","journal-title":"Arch Neurol"},{"issue":"14","key":"536_CR136","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1001\/jama.2013.2973","volume":"309","author":"C Reitz","year":"2013","unstructured":"Reitz C, et al. Variants in the ATP-Binding Cassette Transporter (ABCA7), Apolipoprotein E \u03f54, and the Risk of Late-Onset Alzheimer Disease in African Americans. JAMA. 2013;309(14):1483\u201392.","journal-title":"JAMA"},{"issue":"1","key":"536_CR137","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13195-015-0154-x","volume":"7","author":"JL Del-Aguila","year":"2015","unstructured":"Del-Aguila JL, et al. Role of ABCA7 loss-of-function variant in Alzheimer\u2019s disease: a replication study in European-Americans. Alzheimer\u2019s research & therapy. 2015;7(1):73\u201373.","journal-title":"Alzheimer's research & therapy"},{"issue":"8","key":"536_CR138","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/S1474-4422(15)00133-7","volume":"14","author":"E Cuyvers","year":"2015","unstructured":"Cuyvers E, et al. Mutations in ABCA7 in a Belgian cohort of Alzheimer\u2019s disease patients: a targeted resequencing study. Lancet Neurology. 2015;14(8):814\u201322.","journal-title":"Lancet Neurology"},{"issue":"5","key":"536_CR139","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/ng.3246","volume":"47","author":"S Steinberg","year":"2015","unstructured":"Steinberg S, et al. Loss-of-function variants in ABCA7 confer risk of Alzheimer\u2019s disease. Nat Genet. 2015;47(5):445\u20137.","journal-title":"Nat Genet"},{"key":"536_CR140","doi-asserted-by":"publisher","unstructured":"Bossaerts L, Hens E, Hanseeuw B, Vandenberghe R, Cras P, De Deyn PP, Engelborghs S, Van Broeckhoven C; BELNEU Consortium. Premature termination codon mutations in ABCA7 contribute to Alzheimer's disease risk in Belgian patients. Neurobiol Aging. 2021;106:307.e1\u2013307.e7. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2021.04.023.","DOI":"10.1016\/j.neurobiolaging.2021.04.023"},{"issue":"3","key":"536_CR141","doi-asserted-by":"publisher","first-page":"e79","DOI":"10.1212\/NXG.0000000000000079","volume":"2","author":"HN Cukier","year":"2016","unstructured":"Cukier HN, et al. ABCA7 frameshift deletion associated with Alzheimer disease in African Americans. Neurol Gen. 2016;2(3):e79\u2013e79.","journal-title":"Neurol Gen"},{"issue":"2","key":"536_CR142","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00401-019-01994-1","volume":"138","author":"A De Roeck","year":"2019","unstructured":"De Roeck A, Van Broeckhoven C, Sleegers K. The role of ABCA7 in Alzheimer\u2019s disease: evidence from genomics, transcriptomics and methylomics. Acta Neuropathol. 2019;138(2):201\u201320.","journal-title":"Acta Neuropathol"},{"issue":"6","key":"536_CR143","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s00401-018-1841-z","volume":"135","author":"A De Roeck","year":"2018","unstructured":"De Roeck A, et al. An intronic VNTR affects splicing of ABCA7 and increases risk of Alzheimer\u2019s disease. Acta Neuropathol. 2018;135(6):827\u201337.","journal-title":"Acta Neuropathol"},{"issue":"45","key":"536_CR144","doi-asserted-by":"publisher","first-page":"34503","DOI":"10.1074\/jbc.M600071200","volume":"281","author":"Y Matsumura","year":"2006","unstructured":"Matsumura Y, et al. Characterization and Classification of ATP-binding Cassette Transporter ABCA3 Mutants in Fatal Surfactant Deficiency *. J Biol Chem. 2006;281(45):34503\u201314.","journal-title":"J Biol Chem"},{"issue":"4","key":"536_CR145","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1161\/01.RES.0000237920.70451.ad","volume":"99","author":"RR Singaraja","year":"2006","unstructured":"Singaraja RR, et al. Specific mutations in ABCA1 have discrete effects on ABCA1 function and lipid phenotypes both in vivo and in vitro. Circ Res. 2006;99(4):389\u201397.","journal-title":"Circ Res"},{"issue":"1","key":"536_CR146","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3390\/ijms22010185","volume":"22","author":"FA Garces","year":"2020","unstructured":"Garces FA, Scortecci JF, Molday RS. Functional Characterization of ABCA4 Missense Variants Linked to Stargardt Macular Degeneration. Int J Mol Sci. 2020;22(1):185.","journal-title":"Int J Mol Sci"},{"issue":"48","key":"536_CR147","doi-asserted-by":"publisher","first-page":"34414","DOI":"10.1074\/jbc.M113.508812","volume":"288","author":"F Quazi","year":"2013","unstructured":"Quazi F, Molday RS. Differential phospholipid substrates and directional transport by ATP-binding cassette proteins ABCA1, ABCA7, and ABCA4 and disease-causing mutants. J Biol Chem. 2013;288(48):34414\u201326.","journal-title":"J Biol Chem"},{"issue":"2","key":"536_CR148","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1086\/303018","volume":"67","author":"R Allikmets","year":"2000","unstructured":"Allikmets R. Further evidence for an association of ABCR alleles with age-related macular degeneration. The International ABCR Screening Consortium. Am J Human Gen. 2000;67(2):487\u201391.","journal-title":"Am J Human Gen"},{"issue":"6","key":"536_CR149","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/j.ophtha.2012.01.005","volume":"119","author":"SC Westeneng-van Haaften","year":"2012","unstructured":"Westeneng-van Haaften SC, et al. Clinical and genetic characteristics of late-onset Stargardt\u2019s disease. Ophthalmology. 2012;119(6):1199\u2013210.","journal-title":"Ophthalmology"},{"issue":"8","key":"536_CR150","doi-asserted-by":"publisher","first-page":"3220","DOI":"10.1167\/iovs.18-23881","volume":"59","author":"EH Runhart","year":"2018","unstructured":"Runhart EH, et al. The Common ABCA4 Variant p.Asn1868Ile Shows Nonpenetrance and Variable Expression of Stargardt Disease When Present in trans With Severe Variants. Invest Ophthalmol Visual Sci. 2018;59(8):3220\u201331.","journal-title":"Invest Ophthalmol Visual Sci"},{"issue":"8","key":"536_CR151","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1038\/s41436-018-0414-9","volume":"21","author":"R Sangermano","year":"2019","unstructured":"Sangermano R, et al. Deep-intronic ABCA4 variants explain missing heritability in Stargardt disease and allow correction of splice defects by antisense oligonucleotides. Genet Med. 2019;21(8):1751\u201360.","journal-title":"Genet Med"},{"issue":"23","key":"536_CR152","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1212\/WNL.0000000000002628","volume":"86","author":"T Van den Bossche","year":"2016","unstructured":"Van den Bossche T, et al. Phenotypic characteristics of Alzheimer patients carrying an ABCA7 mutation. Neurology. 2016;86(23):2126\u201333.","journal-title":"Neurology"},{"issue":"1","key":"536_CR153","doi-asserted-by":"publisher","first-page":"e211","DOI":"10.1212\/NXG.0000000000000211","volume":"4","author":"M M\u00e4kel\u00e4","year":"2018","unstructured":"M\u00e4kel\u00e4 M, et al. Alzheimer risk loci and associated neuropathology in a population-based study (Vantaa 85+). Neurol Genet. 2018;4(1):e211.","journal-title":"Neurol Genet"},{"issue":"2","key":"536_CR154","doi-asserted-by":"publisher","first-page":"e224","DOI":"10.1212\/NXG.0000000000000224","volume":"4","author":"P May","year":"2018","unstructured":"May P, et al. Rare ABCA7 variants in 2 German families with Alzheimer disease. Neurology Genetics. 2018;4(2):e224.","journal-title":"Neurology Genetics."},{"key":"536_CR155","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.neulet.2017.04.014","volume":"649","author":"BW Kunkle","year":"2017","unstructured":"Kunkle BW, et al. Targeted sequencing of ABCA7 identifies splicing, stop-gain and intronic risk variants for Alzheimer disease. Neurosci Lett. 2017;649:124\u20139.","journal-title":"Neurosci Lett"},{"issue":"4","key":"536_CR156","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.ajhg.2019.09.006","volume":"105","author":"L Zhao","year":"2019","unstructured":"Zhao L, et al. A Rare Variant Nonparametric Linkage Method for Nuclear and Extended Pedigrees with Application to Late-Onset Alzheimer Disease via WGS Data. Am J Human Gen. 2019;105(4):822\u201335.","journal-title":"Am J Human Gen"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-022-00536-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13024-022-00536-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-022-00536-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T18:31:50Z","timestamp":1700505110000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularneurodegeneration.biomedcentral.com\/articles\/10.1186\/s13024-022-00536-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,27]]},"references-count":156,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["536"],"URL":"https:\/\/doi.org\/10.1186\/s13024-022-00536-w","relation":{},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,27]]},"assertion":[{"value":"17 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31"}}